心膜炎(Pericarditis)：治療薬のグローバル治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables3
List of Figures 4
Introduction 5
Pericarditis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Clinical Trials by G7 Countries: Proportion of Pericarditis to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Pericarditis 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Sanofi 24
Clinical Trial Overview of Sanofi 24
Clinical Trial Overview of Top Institutes / Government 25
Azienda Sanitaria Locale Carbonia 25
Clinical Trial Overview of Azienda Sanitaria Locale Carbonia 25
Maria Vittoria Hospital 26
Clinical Trial Overview of Maria Vittoria Hospital 26
Wolfson Medical Center 27
Clinical Trial Overview of Wolfson Medical Center 27
Vall d’Hebron University Hospital 28
Clinical Trial Overview of Vall d’Hebron University Hospital 28
University Hospital, Brest 29
Clinical Trial Overview of University Hospital, Brest 29
University Hospital, Essen 30
Clinical Trial Overview of University Hospital, Essen 30
Universidad Politecnica de Madrid 31
Clinical Trial Overview of Universidad Politecnica de Madrid 31
University of Cape Town 32
Clinical Trial Overview of University of Cape Town 32
Five Key Clinical Profiles 33
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 51